Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biophys J ; 100(12): 2981-90, 2011 Jun 22.
Article in English | MEDLINE | ID: mdl-21689532

ABSTRACT

RNA interference (RNAi) offers a powerful tool to specifically direct the degradation of complementary RNAs, and thus has great therapeutic potential for targeting diseases. Despite the reported preferences of RNAi, there is still a need for new techniques that will allow for a detailed mechanistic characterization of RNA-induced silencing complex (RISC) assembly and activity to further improve the biocompatibility of modified siRNAs. In contrast to previous reports, we investigated the effects of 2'-O-methyl (2'OMe) modifications introduced at specific positions within the siRNA at the early and late stages of RISC assembly, as well as their influence on target recognition and cleavage directly in living cells. We found that six to 10 2'OMe nucleotides on the 3'-end inhibit passenger-strand release as well as target-RNA cleavage without changing the affinity, strand asymmetry, or target recognition. 2'OMe modifications introduced at the 5'-end reduced activated RISC stability, whereas incorporations at the cleavage site showed only minor effects on passenger-strand release when present on the passenger strand. Our new fluorescence cross-correlation spectroscopy assays resolve different steps and stages of RISC assembly and target recognition with heretofore unresolved detail in living cells, which is needed to develop therapeutic siRNAs with optimized in vivo properties.


Subject(s)
RNA, Small Interfering/metabolism , Spectrometry, Fluorescence/methods , Cell Line , Cell Survival , Humans , Methylation , RNA Interference , RNA-Induced Silencing Complex/metabolism
2.
Nucleic Acids Res ; 36(20): 6439-49, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18842624

ABSTRACT

Studies of RNA interference (RNAi) provide evidence that in addition to the well-characterized cytoplasmic mechanisms, nuclear mechanisms also exist. The mechanism by which the nuclear RNA-induced silencing complex (RISC) is formed in mammalian cells, as well as the relationship between the RNA silencing pathways in nuclear and cytoplasmic compartments is still unknown. Here we show by applying fluorescence correlation and cross-correlation spectroscopy (FCS/FCCS) in vivo that two distinct RISC exist: a large approximately 3 MDa complex in the cytoplasm and a 20-fold smaller complex of approximately 158 kDa in the nucleus. We further show that nuclear RISC, consisting only of Ago2 and a short RNA, is loaded in the cytoplasm and imported into the nucleus. The loaded RISC accumulates in the nucleus depending on the presence of a target, based on an miRNA-like interaction with impaired cleavage of the cognate RNA. Together, these results suggest a new RISC shuttling mechanism between nucleus and cytoplasm ensuring concomitant gene regulation by small RNAs in both compartments.


Subject(s)
Cell Nucleus/metabolism , Cytoplasm/metabolism , RNA-Induced Silencing Complex/metabolism , Active Transport, Cell Nucleus , Argonaute Proteins , Cell Line , Eukaryotic Initiation Factor-2/analysis , Humans , RNA, Small Interfering/metabolism , RNA-Induced Silencing Complex/chemistry , Spectrometry, Fluorescence/methods , RNA, Small Untranslated
3.
Chembiochem ; 9(8): 1251-9, 2008 May 23.
Article in English | MEDLINE | ID: mdl-18435448

ABSTRACT

Ku is a predominantly nuclear protein that functions as a DNA double-strand-break (DSB) binding protein and regulatory subunit of the DNA-dependent protein kinase (DNA-PK). DNA-PK is involved in synapsis and remodeling of broken DNA ends during nonhomologous end-joining (NHEJ) of DNA DSBs. It has also recently been demonstrated that Ku plays roles in cytoplasmic and membrane processes, namely: interaction with matrix metalloproteinase 9, acting as a co-receptor for parvoviral infection, and also interacting with cell polarity protein, Par3. We present a method for creating stable expression of Ku-eGFP in CHO cells and extend the procedure to purify Ku-eGFP for in vitro assaying. We demonstrated that Ku-eGFP localizes to the nucleus of HeLa cells upon microinjection into the cytoplasm as well as localizing to laser induced DNA damage. We also characterized the diffusional dynamics of Ku in the nucleus and in the cytoplasm using fluorescence correlation spectroscopy (FCS). The FCS data suggest that whereas the majority of Ku (70%) in the nucleus is mobile and freely diffusing, in a cellular context, there also exists a significant slow process fraction (30%). Strikingly, in the cytoplasm, this immobile/slow moving fraction is even more pronounced (45%).


Subject(s)
Antigens, Nuclear/isolation & purification , Antigens, Nuclear/metabolism , DNA-Binding Proteins/isolation & purification , DNA-Binding Proteins/metabolism , Green Fluorescent Proteins/metabolism , Animals , Antigens, Nuclear/genetics , Cell Line , Cell Nucleus/metabolism , Cricetinae , DNA/metabolism , DNA-Binding Proteins/genetics , Dimerization , Green Fluorescent Proteins/genetics , Humans , Ku Autoantigen , Phosphorylation
SELECTION OF CITATIONS
SEARCH DETAIL
...